Initial small trials from 2016 to 2017, including EXSCEL, FIGHT, and LIVE, were not supportive of the use of GLP-1RAs in HFrEF with negative outcomes related to cardiovascular events [53,54,55]
Phoenix Pharmaceuticals: Institutional Research Catalog Phoenix Pharmaceuticals is the deep-catalog option for institutional labs that need research peptides, as well as antibodies and assay kits
In addition to the green chemistry efforts mentioned, companies are evaluating next-generation peptide assembly methods
*Correspondence: Juan Huang, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers